tert-Butyl (4-bromo-2-methylbenzyl)(isopropyl)carbamate

Catalog No.: 
ACAXPP117
CAS No.: 
2358751-29-6
Molecular Formula: 
C16H24BrNO2
Molecular Weight: 
342.28
tert-Butyl (4-bromo-2-methylbenzyl)(isopropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$395.00InquiryInquiry
1g98%$1137.00InquiryInquiry
5g98%$2276.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (4-bromo-2-methylbenzyl)(isopropyl)carbamate
IUPAC Nametert-butyl (4-bromo-2-methylbenzyl)(isopropyl)carbamate
MDL No.MFCD31924857
Molecular FormulaC16H24BrNO2
Molecular Weight342.28
SMILESO=C(OC(C)(C)C)N(CC1=CC=C(Br)C=C1C)C(C)C
InChI KeyBLAAZKOYZAKAFK-UHFFFAOYSA-N
Synonymtert-Butyl 4-bromo-2-methylbenzyl(isopropyl)carbamate;Carbamic acid, N-[(4-bromo-2-methylphenyl)methyl]-N-(1-methylethyl)-, 1,1-dimethylethyl ester
CAS No.2358751-29-6

Synthetic Route by SureRoute

1. ACAXPP117 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWCVT965 route compound structure diagram
    ACWCVT96551170-55-9In Stock
  2. Plus
  3. ACRBUA286 route compound structure diagram
    ACRBUA286156001-49-9In Stock
  4. Then
  5. ACAXPP117 route product structure diagram
    ACAXPP1172358751-29-6
Inquiry

2. ACAXPP117 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXQPZ815 route compound structure diagram
    ACXQPZ8151352896-24-2In Stock
  4. Then
  5. ACAXPP117 route product structure diagram
    ACAXPP1172358751-29-6
Inquiry

3. ACAXPP117 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAXPP117 route product structure diagram
    ACAXPP1172358751-29-6
Inquiry

Comments (0)